Corneal collagen crosslinking
SCHWIND eye-tech-solutions says the company is the first and only manufacturer of excimer laser systems to offer the integrated SCHWIND CXL-365 vario system for corneal collagen crosslinking (CXL). 'CXL using ultraviolet A (UVA) light and riboflavin (vitamin B2) was introduced as a clinical application to stabilise the cornea by inducing crosslinks within and between collagen fibres. CXL has been investigated extensively and has been shown clinically not only to arrest the progression of keratoconic or post-LASIK ectasia but also to exert a moderately positive effect on visual status,' said a company spokeswoman.
Latest Articles
Towards a Unified IOL Classification
The new IOL functional classification needs a strong and unified effort from surgeons, societies, and industry.
The 5 Ws of Post-Presbyopic IOL Enhancement
Fine-tuning refractive outcomes to meet patient expectations.
AI Shows Promise for Meibography Grading
Study demonstrates accuracy in detecting abnormalities and subtle changes in meibomian glands.
Are There Differences Between Male and Female Eyes?
TOGA Session panel underlined the need for more studies on gender differences.
Simulating Laser Vision Correction Outcomes
Individualised planning models could reduce ectasia risk and improve outcomes.
Need to Know: Aberrations, Aberrometry, and Aberropia
Understanding the nomenclature and techniques.
When Is It Time to Remove a Phakic IOL?
Close monitoring of endothelial cell loss in phakic IOL patients and timely explantation may avoid surgical complications.
Delivering Uncompromising Cataract Care
Expert panel considers tips and tricks for cataracts and compromised corneas.
Organising for Success
Professional and personal goals drive practice ownership and operational choices.